AUCKLAND, NEW ZEALAND: Cancer diagnostics business, Pacific Edge Limited (PEB) will lodge an application with the Australian Stock Exchange (ASX) to dual list as a Foreign Exempt Entity. Subject to the ASX accepting the application, PEB expects to be dual-listed on the ASX by the end of September 2021. Pacific Edge intends to maintain its…